Dr. Randall Gates from Gates Brain Health stopped by Morning Break to talk about how Whole-Body MRI is practical for staging ...

Randomized Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen Sodium (Bcl-2 antisense) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Both baseline ...

The impact of glucagon-like peptide-1 agonists on MGUS progression in patients with type 2 diabetes. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

Multiple myeloma treatment involved carfilzomib, bendamustine, dexamethasone, and zoledronic acid, alongside MRI scans and radiation therapy. Severe spinal fractures led to significant height loss and ...

Explore the unique mechanisms of bispecific antibodies versus CAR T-cell therapies in treating multiple myeloma and their clinical implications. In this episode, experts begin outlining how bispecific ...

The blood cancer multiple myeloma, which involves infection-fighting plasma cells in the bone marrow, affects only about 1% of all cancers -- predominantly individuals over age 65. The disease ...

Multiple myeloma affects many systems in the body, including the bones, blood, kidneys, and immune system. The symptoms that may have sent you to the doctor in the first place, such as back or leg ...

Most patients present with asymptomatic, early disease but are found to have abnormal blood and/or urine tests that lead to the diagnosis. In asymptomatic patients, laboratory findings, including ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma ...